GANC_HUMAN - dbPTM
GANC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GANC_HUMAN
UniProt AC Q8TET4
Protein Name Neutral alpha-glucosidase C
Gene Name GANC
Organism Homo sapiens (Human).
Sequence Length 914
Subcellular Localization
Protein Description Has alpha-glucosidase activity..
Protein Sequence MEAAVKEEISLEDEAVDKNIFRDCNKIAFYRRQKQWLSKKSTYQALLDSVTTDEDSTRFQIINEASKVPLLAEIYGIEGNIFRLKINEETPLKPRFEVPDVLTSKPSTVRLISCSGDTGSLILADGKGDLKCHITANPFKVDLVSEEEVVISINSLGQLYFEHLQILHKQRAAKENEEETSVDTSQENQEDLGLWEEKFGKFVDIKANGPSSIGLDFSLHGFEHLYGIPQHAESHQLKNTGDGDAYRLYNLDVYGYQIYDKMGIYGSVPYLLAHKLGRTIGIFWLNASETLVEINTEPAVEYTLTQMGPVAAKQKVRSRTHVHWMSESGIIDVFLLTGPTPSDVFKQYSHLTGTQAMPPLFSLGYHQCRWNYEDEQDVKAVDAGFDEHDIPYDAMWLDIEHTEGKRYFTWDKNRFPNPKRMQELLRSKKRKLVVISDPHIKIDPDYSVYVKAKDQGFFVKNQEGEDFEGVCWPGLSSYLDFTNPKVREWYSSLFAFPVYQGSTDILFLWNDMNEPSVFRGPEQTMQKNAIHHGNWEHRELHNIYGFYHQMATAEGLIKRSKGKERPFVLTRSFFAGSQKYGAVWTGDNTAEWSNLKISIPMLLTLSITGISFCGADIGGFIGNPETELLVRWYQAGAYQPFFRGHATMNTKRREPWLFGEEHTRLIREAIRERYGLLPYWYSLFYHAHVASQPVMRPLWVEFPDELKTFDMEDEYMLGSALLVHPVTEPKATTVDVFLPGSNEVWYDYKTFAHWEGGCTVKIPVALDTIPVFQRGGSVIPIKTTVGKSTGWMTESSYGLRVALSTKGSSVGELYLDDGHSFQYLHQKQFLHRKFSFCSSVLINSFADQRGHYPSKCVVEKILVLGFRKEPSSVTTHSSDGKDQPVAFTYCAKTSILSLEKLSLNIATDWEVRII
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
40UbiquitinationQKQWLSKKSTYQALL
HHHHHCCHHHHHHHH
44.66-
93UbiquitinationINEETPLKPRFEVPD
ECCCCCCCCCCCCCC
35.04-
198UbiquitinationDLGLWEEKFGKFVDI
HHCHHHHHHCEEEEE
48.15-
419AcetylationKNRFPNPKRMQELLR
CCCCCCHHHHHHHHH
68.1220167786
428AcetylationMQELLRSKKRKLVVI
HHHHHHHCCCCEEEE
50.6012437947
428UbiquitinationMQELLRSKKRKLVVI
HHHHHHHCCCCEEEE
50.60-
429AcetylationQELLRSKKRKLVVIS
HHHHHHCCCCEEEEC
56.8812437957
453UbiquitinationYSVYVKAKDQGFFVK
CEEEEEECCCCEEEE
44.88-
608PhosphorylationMLLTLSITGISFCGA
EEEEEECCCEEECCC
25.70-
611PhosphorylationTLSITGISFCGADIG
EEECCCEEECCCCCC
18.81-
626PhosphorylationGFIGNPETELLVRWY
CCCCCCCHHHHHHHH
32.94-
707AcetylationVEFPDELKTFDMEDE
EECCCHHCCCCCCCC
45.1330588879
750PhosphorylationEVWYDYKTFAHWEGG
CCEEEEEEEECCCCC
21.59-
833UbiquitinationQKQFLHRKFSFCSSV
HHHHHHHHHCCHHHH
34.3121906983
872PhosphorylationGFRKEPSSVTTHSSD
EECCCCCCCEEECCC
33.91-
878PhosphorylationSSVTTHSSDGKDQPV
CCCEEECCCCCCCCE
42.66-
888PhosphorylationKDQPVAFTYCAKTSI
CCCCEEEEEEECCCE
14.14-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of GANC_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GANC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GANC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of GANC_HUMAN !!

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
DB00491Miglitol
Regulatory Network of GANC_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP